Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-30296-x.pdf
Reference50 articles.
1. Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England journal of medicine 352, 987–996, https://doi.org/10.1056/NEJMoa043330 (2005).
2. Carson, M. J., Doose, J. M., Melchior, B., Schmid, C. D. & Ploix, C. C. CNS immune privilege: hiding in plain sight. Immunological reviews 213, 48–65, https://doi.org/10.1111/j.1600-065X.2006.00441.x (2006).
3. Hickey, W. F., Hsu, B. L. & Kimura, H. T-lymphocyte entry into the central nervous system. Journal of neuroscience research 28, 254–260, https://doi.org/10.1002/jnr.490280213 (1991).
4. Laman, J. D. & Weller, R. O. Drainage of cells and soluble antigen from the CNS to regional lymph nodes. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology 8, 840–856, https://doi.org/10.1007/s11481-013-9470-8 (2013).
5. Safdari, H., Hochberg, F. H. & Richardson, E. P. Jr. Prognostic value of round cell (lymphocyte) infiltration in malignant gliomas. Surgical neurology 23, 221–226 (1985).
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of cell-based immunotherapies on patients with glioma: an umbrella review of systematic reviews and meta-analysis protocol;BMJ Open;2023-12
2. In vitro evaluation of Axitinib and Sorafenib treatment in glioblastoma cell viability and morphology;Romanian Journal of Morphology and Embryology;2023-07-28
3. Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma;Cancers;2023-07-22
4. Efficacy and safety of innate and adaptive immunotherapy combined with standard of care in high-grade gliomas: a systematic review and meta-analysis;Frontiers in Immunology;2023-07-06
5. An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma;International Journal of Molecular Sciences;2023-07-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3